» Articles » PMID: 32266943

Transcription Factor Tcf4 is the Preferred Heterodimerization Partner for Olig2 in Oligodendrocytes and Required for Differentiation

Overview
Specialty Biochemistry
Date 2020 Apr 9
PMID 32266943
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Development of oligodendrocytes and myelin formation in the vertebrate central nervous system is under control of several basic helix-loop-helix transcription factors such as Olig2, Ascl1, Hes5 and the Id proteins. The class I basic helix-loop-helix proteins Tcf3, Tcf4 and Tcf12 represent potential heterodimerization partners and functional modulators for all, but have not been investigated in oligodendrocytes so far. Using mouse mutants, organotypic slice and primary cell cultures we here show that Tcf4 is required in a cell-autonomous manner for proper terminal differentiation and myelination in vivo and ex vivo. Partial compensation is provided by the paralogous Tcf3, but not Tcf12. On the mechanistic level Tcf4 was identified as the preferred heterodimerization partner of the central regulator of oligodendrocyte development Olig2. Both genetic studies in the mouse as well as functional studies on enhancer regions of myelin genes confirmed the relevance of this physical interaction for oligodendrocyte differentiation. Considering that alterations in TCF4 are associated with syndromic and non-syndromic forms of intellectual disability, schizophrenia and autism in humans, our findings point to the possibility of an oligodendroglial contribution to these disorders.

Citing Articles

Activation-derepression synergy enables a bHLH network to coordinate a signal-specific fate response.

Nandagopal S, Terrio A, Vicente F, Megason S, Jambhekar A, Lahav G Cell Rep. 2024; 43(12):115077.

PMID: 39671287 PMC: 11774475. DOI: 10.1016/j.celrep.2024.115077.


The E3 ubiquitin ligase Nedd4 fosters developmental myelination in the mouse central and peripheral nervous system.

Fimiani C, Pereira J, Gerber J, Berg I, DeGeer J, Bachofner S Glia. 2024; 73(2):422-444.

PMID: 39511974 PMC: 11662984. DOI: 10.1002/glia.24642.


Transcription factor 4 expression in the developing non-human primate brain: a comparative analysis with the mouse brain.

Burette A, Vihma H, Smith A, Ozarkar S, Bennett J, Amaral D Front Neuroanat. 2024; 18:1478689.

PMID: 39502395 PMC: 11534587. DOI: 10.3389/fnana.2024.1478689.


Reduced Expression of Oligodendrocyte Linage-Enriched Transcripts During the Endoplasmic Reticulum Stress/Integrated Stress Response.

Gao Y, Slomnicki L, Kilanczyk E, Forston M, Pietrzak M, Rouchka E ASN Neuro. 2024; 16(1):2371162.

PMID: 39024571 PMC: 11262469. DOI: 10.1080/17590914.2024.2371162.


Fluoxetine Rescues Excessive Myelin Formation and Psychological Behaviors in a Murine PTSD Model.

Yin C, Luo K, Zhu X, Zheng R, Wang Y, Yu G Neurosci Bull. 2024; 40(8):1037-1052.

PMID: 39014176 PMC: 11306862. DOI: 10.1007/s12264-024-01249-4.


References
1.
Murre C, McCaw P, Vaessin H, Caudy M, Jan L, Jan Y . Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell. 1989; 58(3):537-44. DOI: 10.1016/0092-8674(89)90434-0. View

2.
Zhou Q, Choi G, Anderson D . The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron. 2001; 31(5):791-807. DOI: 10.1016/s0896-6273(01)00414-7. View

3.
Sherafat A, Hill R, Nishiyama A . Organotypic Slice Cultures to Study Oligodendrocyte Proliferation, Fate, and Myelination. Methods Mol Biol. 2018; 1791:145-156. PMC: 6372239. DOI: 10.1007/978-1-4939-7862-5_11. View

4.
Hornig J, Frob F, Vogl M, Hermans-Borgmeyer I, Tamm E, Wegner M . The transcription factors Sox10 and Myrf define an essential regulatory network module in differentiating oligodendrocytes. PLoS Genet. 2013; 9(10):e1003907. PMC: 3814293. DOI: 10.1371/journal.pgen.1003907. View

5.
Yu Y, Chen Y, Kim B, Wang H, Zhao C, He X . Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell. 2013; 152(1-2):248-61. PMC: 3553550. DOI: 10.1016/j.cell.2012.12.006. View